Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in MRI-HIFU for Uterine Fibroids and Adenomyosis
NCT03937401Phase 4Unknown
- Sponsor
- Turku University Hospital
- Start
- Feb 2019
- Primary completion
- Dec 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of oxytocin in uterine fibroid, adenomyosis, sponsored by Turku University Hospital. Status: unknown.
02
Drugs
oxytocin
03
Conditions
uterine fibroidadenomyosis
Beyond the preview
Go deeper on NCT03937401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937401.